This site is intended only for healthcare professionals resident in the United Kingdom
Gonzales D et al. Varenicline, an a4ß2 nicotinic acetylcholine receptor partial agonist, vs sustained release bupropion and placebo for smoking cessation. A randomized controlled trial. JAMA 2006; 296:47-55.